Evidence map›Paper›PMID 38525783›Full record

ArticleMethods and protocols2024

Development and Validation of Micro-Azocasein Assay for Quantifying Bromelain.

Krishna Pillai, Javed Akhter, Ahmed H Mekkawy, Sarah J Valle, David L Morris

Open access · goldAbstract read
In one paragraph

Article in Methods and protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Krishna PillaiMucpharm Pty Ltd., Sydney, NSW 2217, Australia.
Javed AkhterMucpharm Pty Ltd., Sydney, NSW 2217, Australia.
Ahmed H MekkawyMucpharm Pty Ltd., Sydney, NSW 2217, Australia.ORCID 0000-0001-7162-8936
Sarah J ValleMucpharm Pty Ltd., Sydney, NSW 2217, Australia.
David L MorrisMucpharm Pty Ltd., Sydney, NSW 2217, Australia.
St George Hospital · AUSutherland Hospital · AU

Funding

Mucpharm Pty Ltd N/A
6 · The paper itself

Abstract

The proteolytic activity of enzymes may be evaluated by a colorimetric method with azocasein. Hence, we developed a micro-assay to quantify bromelain using azocasein. A total of 250 µL of 1.0% azocasein in dH

Indexed as

azocaseinbromelainenzymesN-acetylcysteineproteolytic activityvalidation

Identifiers

PMID38525783
PMCPMC10961761
OpenAlexW4392865122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.